PMC:7036343 / 2872-3140 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"58","span":{"begin":52,"end":57},"obj":"Chemical"},{"id":"59","span":{"begin":110,"end":118},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C558899"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T36","span":{"begin":110,"end":118},"obj":"SP_7"},{"id":"T35","span":{"begin":261,"end":267},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":110,"end":118},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":61,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":73,"end":88},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":0,"end":119},"obj":"Sentence"},{"id":"T20","span":{"begin":120,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Regardless of the case report, I still believe that LPV/r is a promising antiviral agent for the treatment of COVID-19. However, it is clear that well-designed studies have to be carried out to build more evidence so that they can be recommended as therapeutic agents."}